Subject Retention

Subject Retention - Axcellant

Subject Retention

  1. Feb 28, 2025

What Does the ‘Subject Retention’ Mean?

Subject retention refers to the process of keeping participants enrolled and actively engaged in a clinical trial from the beginning to the end of the study. It involves strategies and methods implemented by researchers to ensure that subjects continue to participate in all required study activities, follow-up visits, and assessments throughout the duration of the trial.

Effective subject retention is crucial for maintaining the statistical power of a study and minimizing bias that can result from participant dropout. It often includes various approaches such as regular communication with participants, providing reminders for appointments, addressing concerns promptly, and sometimes offering appropriate incentives or compensation for time and travel expenses.

Why Is the ‘Subject Retention’ Important in Clinical Research?

Subject retention is critical for maintaining the integrity and validity of clinical research studies. High retention rates ensure that the study results accurately reflect the true effects of the intervention being tested, as significant dropout rates can lead to biased or inconclusive findings.

Moreover, successful subject retention contributes to the efficient use of resources and timely completion of clinical trials. By minimizing the need to recruit additional participants to compensate for dropouts, researchers can reduce costs, adhere to study timelines, and ultimately accelerate the development of new treatments or interventions.

Good Practices and Procedures

  1. Implement a personalized patient portal for easy access to study information, appointment scheduling, and secure communication with the research team.
  2. Develop a “study buddy” system, pairing participants for mutual support and encouragement throughout the trial.
  3. Offer flexible visit scheduling, including evenings and weekends, to accommodate participants’ work and personal commitments.
  4. Create engaging, educational content about the study’s progress and potential impact to maintain participant interest and motivation.
  5. Establish a rapid response protocol for addressing participants’ concerns or questions within 24 hours to demonstrate commitment to their well-being.

Related Terms

Resources

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…

From Half-Life to Clinical Impact: Mastering Time-Critical Supply Chains

How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…